Results 181 to 190 of about 82,231 (299)
Editorial: Opportunities and challenges in drug repurposing. [PDF]
Camps I +3 more
europepmc +1 more source
Image analysis method for measurement and prediction of intra‐matrix IgG diffusion
Experimental and image analysis workflow for b‐IgG diffusion in hyaluronic acid (HA) matrix. Abstract Measurement and imaging of intra‐matrix protein therapeutics diffusion is important due to the emergence of injectable biologics currently in various stages of research and clinical testing.
Riya Debbarma +2 more
wiley +1 more source
Drug-disease networks and drug repurposing. [PDF]
Polanco A, Newman MEJ.
europepmc +1 more source
Abstract Artificial intelligence and automation are no longer just buzzwords in the biopharmaceutical industry. The manufacturing of a class of biologics, comprising monoclonal antibodies, cell therapies, and gene therapies, is far more complex than that of traditional small molecule drugs.
Shyam Panjwani, Hao Wei, John Mason
wiley +1 more source
Why add another catalyst when the product itself holds the power to catalyze its own formation? Autocatalysis in synthetic chemistry enhances reaction efficiency and uncovers novel catalytic behavior across both closed‐shell and open‐shell systems, expanding reactivity and enabling innovative design strategies.
Jaspreet Kaur, Joshua P. Barham
wiley +1 more source
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation. [PDF]
Corbett A +20 more
europepmc +1 more source
Thermal defrosting limits desublimator efficiency in freeze‐drying. This review and case study compares thermal versus mechanical regeneration, links frost properties and external heat transfer to energy demand, and summarizes pilot‐scale scraping results enabling single‐unit, continuous lyophilization.
Moritz Krummenacher +3 more
wiley +1 more source
Benchmarking heterogeneous network-based methods for drug repurposing. [PDF]
Nguyen TT, Pawitan Y, Calza S, Vu TN.
europepmc +1 more source
Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?
Pediatric drug development has achieved remarkable success in the last 20 years with over 1,000 products studied in pediatric patients. This success has been driven in part by an increased understanding of pediatric disease processes. The aspect that has been largely overlooked is the potential adverse effect of new drugs on pediatric developmental ...
Gilbert J. Burckart +6 more
wiley +1 more source
AI in drug repurposing for cancer therapies. [PDF]
Saddique MN, Abu Nahla U.
europepmc +1 more source

